NASDAQ:KTTA

Pasithea Therapeutics Stock Insider Trading

etoro logo Buy KTTA
*Your capital is at risk
$0.638
-0.0068 (-1.05%)
At Close: Jun 03, 2026

Pasithea Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 99.68. In total, the insiders bought 20.43M and sold 1.92K KTTA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
99.68
Buy 20.43M shares
Sell 1.92K shares
98% Buy Activity
Weak Positive Correlation
Buy Signal High Confidence
May 01, 2026

Analysis Breakdown:

  • Strongly supported by a very high Insider Power Score of 99.68.
  • Confidence increased due to high data reliability score of 90.
  • Supported by overwhelming buy-side pressure (98% buys).

Historical Insider Trades

Date Type Person Role Amount
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Marques Tiago
Chief Executive Officer
CEO / President 1 756 069
Value: $1.48M
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Steinman Lawrence
Director
Director 152 783
Value: $128.5K
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Dumesnil Simon
Director
Director 152 783
Value: $128.5K
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Schneiderman Daniel H
Chief Financial Officer
C-Suite Officer 1 129 323
Value: $949.8K
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Krishnan Kartik
Chief Medical Officer
Officer 1 129 323
Value: $949.8K
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Leahy Emer
Director
Director 152 783
Value: $128.5K
May 01, 2026
Buy
Stock Option (right to buy)
A-Award
Novak Alfred J
Director
Director 152 783
Value: $128.5K
May 01, 2026
Buy
Common Stock
J-Other
Krishnan Kartik
Officer
Officer 0
Value: $0
Apr 09, 2026
Buy
Common Stock
Coastlands Capital Lp
10 Percent Owner
10% Owner 0
Value: $0
Apr 09, 2026
Buy
Pre-funded Warrant
Coastlands Capital Lp
10 Percent Owner
10% Owner 11 233 334
Value: $11.2K
Nov 28, 2025
Buy
Common Stock
P-Purchase
Steinman Lawrence
Director
Director 133 333
Value: $100.0K
Nov 28, 2025
Buy
Common Stock
A-Award
Schneiderman Daniel H
Chief Financial Officer
C-Suite Officer 26 667
Value: $20.0K
Nov 28, 2025
Buy
Common Stock
P-Purchase
Marques Tiago
Chief Executive Officer
CEO / President 33 333
Value: $25.0K
Nov 28, 2025
Buy
Common Stock
P-Purchase
Dumesnil Simon
Director
Director 33 333
Value: $25.0K
Nov 28, 2025
Buy
Common Stock
A-Award
Leahy Emer
Director
Director 33 333
Value: $25.0K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Steinman Lawrence
Director
Director 242 913
Value: $173.7K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Schneiderman Daniel H
Chief Financial Officer
C-Suite Officer 317 266
Value: $226.8K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Novak Alfred J
Director
Director 42 913
Value: $30.7K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Marques Tiago
Chief Executive Officer
CEO / President 493 341
Value: $352.7K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Leahy Emer
Director
Director 42 913
Value: $30.7K
Oct 24, 2025
Buy
Stock Option (right to buy)
A-Award
Dumesnil Simon
Director
Director 42 913
Value: $30.7K
May 12, 2025
Sell
Common Stock
S-Sale
Marques Tiago
Chief Executive Officer
CEO / President 960
Value: $792
May 12, 2025
Sell
Common Stock
S-Sale
Marques Tiago
Chief Executive Officer
CEO / President 960
Value: $792
Jun 13, 2024
Buy
Common Stock
A-Award
Novak Alfred J
Director
Director 2 750
Value: $15.5K
Jun 13, 2024
Buy
Common Stock
A-Award
Novak Alfred J
Director
Director 2 750
Value: $15.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PASITHEA THERAPEUTICS CORP.
Pasithea Therapeutics
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. It also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. The company was incorporated in 2020 and is headquartered in Miami Beach, Florida....
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE